TOMIKA WASHINGTON: Open Payments
NPI 1104309178 · OLIVE BRANCH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 16 payments from 9 companies in 2025. Trend: 2023 $99 · 2024 $408 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $150 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
| Corium, LLC | 1 | $19 |
Products named: VRAYLAR, Auvelity, ABILIFY ASIMTUFII, FANAPT, TRINTELLIX, UZEDY, REXULTI, Jornay PM.
Industry payments across MS — which companies pay providers there.
